Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autogenous Vaccine for Recurrent Juvenile Laryngeal Papilloma
NCT00002454Phase 2Unknown
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Dec 1971
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autogenous papilloma vaccine in juvenile laryngeal papillomatosis (JLP), sponsored by University of Medicine and Dentistry of New Jersey. Primary endpoint: Immune response. Status: unknown.
02
Drugs
autogenous papilloma vaccine
03
Conditions
juvenile laryngeal papillomatosis (JLP)
Beyond the preview
Go deeper on NCT00002454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002454.